Intec Bioplastics, Inc.
Raising nowOperatingIndustrial & Manufacturing · Santa Monica, CA
Intec Bioplastics develops plant-based resins and packaging meant to replace petroleum plastics, built to run on existing molding and film-extrusion equipment. Its main product is a recyclable stretch-wrap film for logistics and warehousing; grow bags and milk jugs are in development.
This company has an open fundraising round.
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Principal holders% as the filing states it, Feb 19, 2026
- Edward Showalter1,000,000,000 Common Stock71.3%of company
- Robert Liska25,500,000 Common Stock1.81%of company
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
4 peopleNames and titles as disclosed on SEC Form C, SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
- Form 1-UMay 20, 20260001096906-26-000835EDGAR
- Form QUALIFFeb 19, 20269999999994-26-000041EDGAR
- Form 1-A/AFeb 19, 20260001096906-26-000240EDGAR
- Form 1-AJan 21, 20260001096906-26-000119EDGAR
- Form C/AAug 28, 20240001096906-24-001812EDGAR
- Form C/AAug 27, 20240001096906-24-001805EDGAR
- Form C/AAug 1, 20240001096906-24-001612EDGAR
- Form CJul 18, 20240001096906-24-001543EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.